0.5822  -0.078 (-11.8%)		07-16 15:04
Open: 0.669 High: 0.669 Volume: 922,984		Pre. Close: 0.6601 Low: 0.58 Market Cap: 20(M)

Short term
Mid term
Targets	6-month :	0.81	1-year :	0.94
Resists	First :	0.69	Second :	0.81
Pivot price	0.65
Supports	First :	0.5	Second :	0.42
MAs	MA(5) :	0.59	MA(20) :	0.66
	MA(100) :	0.98	MA(250) :	1.34
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	36.1	D(3) :	25.3
RSI	RSI(14): 38.9
52-week	High :	4	Low :	0.5

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ BEAT ] has closed above bottom band by 22.2%. Bollinger Bands are 24% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	0.7 - 0.7	0.7 - 0.71
Low:	0.54 - 0.55	0.55 - 0.55
Close:	0.65 - 0.66	0.66 - 0.67

HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.

Tue, 30 Jun 2026
HeartBeam (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study - The Globe and Mail

Sat, 27 Jun 2026
HeartBeam (BEAT) Stock Sees Fair Value Cut As Analysts Weigh Dilution And Slower Ramp - Yahoo Finance

Thu, 25 Jun 2026
BEAT Forecast — Price Target — Prediction for 2027 - TradingView

Wed, 24 Jun 2026
Leadership shakeup as HeartBeam (NASDAQ: BEAT) reorganizes for global ECG push - Stock Titan

Wed, 24 Jun 2026
HeartBeam to license its ECG tech as CEO transitions out - Stock Titan

Mon, 22 Jun 2026
[8-K] HeartBeam, Inc. Reports Material Event - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Equipment & Services
Shares Out	56 (M)
Shares Float	47 (M)
Held by Insiders	13.8 (%)
Held by Institutions	9.2 (%)
Shares Short	1,790 (K)
Shares Short P.Month	2,300 (K)

EPS	-0.57
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-195.2 %
Return on Equity (ttm)	-495.7 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-0.37
Qtrly Earnings Growth	0 %
Operating Cash Flow	-13 (M)
Levered Free Cash Flow	-6 (M)

PE Ratio	-1.06
PEG Ratio	0
Price to Book value	59.25
Price to Sales	0
Price to Cash Flow	-2.51

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.